Ercros (ECR)

Currency in EUR
3.150
+0.095(+3.11%)
Closed·
ECR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.0803.150
52 wk Range
2.2303.610
Key Statistics
Bid/Ask
3.09 / 3.20
Prev. Close
3.055
Open
3.1
Day's Range
3.08-3.15
52 wk Range
2.23-3.61
Volume
59.28K
Average Volume (3m)
100.07K
1-Year Change
-14.19%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ECR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Ercros News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Ercros Company Profile

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, anti-hypertensives, and anti-ulcer drugs. This segment’s products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Industry
Chemicals
Employees
1318
Market
Spain

Compare ECR to Peers and Sector

Metrics to compare
ECR
Peers
Sector
Relationship
P/E Ratio
−6.4x3.2x0.3x
PEG Ratio
-−0.090.00
Price/Book
1.0x0.9x1.6x
Price / LTM Sales
0.4x0.8x1.4x
Upside (Analyst Target)
-39.0%22.6%
Fair Value Upside
Unlock15.0%−0.5%Unlock

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
-- / --
Revenue / Forecast
161.48M / --
EPS Revisions
Last 90 days

ECR Income Statement

People Also Watch

16.940
REP
-0.62%
3.1640
SABE
-0.57%
3.7300
TEF
-0.05%
50.100
IDR
-0.79%
14.43
PUIGb
-2.24%

FAQ

What Stock Exchange Does Ercros Trade On?

Ercros is listed and trades on the Madrid Stock Exchange stock exchange.

What Is the Stock Symbol for Ercros?

The stock symbol for Ercros is "ECR."

What Is the Ercros (ECR) Afterhours Price Today? (Afterhours variable test: 0.000) Current Date: 18 Nov 2025

After hours price: 0.000. After hours price change (units): 0.000. Price change percentage: 0.000%

What Is the Ercros Market Cap?

As of today, Ercros market cap is 288.02M.

What Is Ercros's Earnings Per Share (TTM)?

The Ercros EPS (TTM) is 0.00.

When Is the Next Ercros Earnings Date?

Ercros will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is ECR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Ercros Stock Split?

Ercros has split 4 times.

How Many Employees Does Ercros Have?

Ercros has 1318 employees.

What is the current trading status of Ercros (ECR)?

As of 18 Nov 2025, Ercros (ECR) is trading at a price of 3.150, with a previous close of 3.055. The stock has fluctuated within a day range of 3.080 to 3.150, while its 52-week range spans from 2.230 to 3.610.

What Is the ECR After Hours Price?

ECR's last after hours stock price is 0.000, the stock has decreased by 0.000, or 0.000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.